HHS announced Thursday (March 27) plans to cut an additional 3,500 full-time FDA employees, a move that industry experts are already warning could disrupt the biotech sector by delaying critical approvals, inspections and policy decisions--and in turn potentially slowing mergers, acquisitions and investment.
FREE TRIAL Receive 30 days of no-obligation access. SIGN UP
Home
Breaking News
HHS’ Major New Reorg Includes Agency Mergers, 10K More Job Cuts
A newly announced HHS reorganization as part of the Trump administration’s effort to cut costs and staff will eliminate about 10,000 additional employees and several of HHS’ constituent agencies, creating a new “Administration for a Healthy America,” new offices for strategy and enforcement, and shifting the focus of agencies like the Centers for Disease Control and Prevention (CDC).
Dems, Unions Object As Kennedy Predicts ‘A Painful Period’ For HHS
More NIH Cuts Coming As Lawmakers, Former Officials Already Warn Of Brain Drain
Top Story
CCIIO Pledges Flexibility, Sets Sept. 12 Rate Deadline Amid APTC Uncertainty
INDIANAPOLIS -- The Trump administration’s exchange director, Peter Nelson, told a panel of state insurance commissioners Sunday he is aware of the significant uncertainty regulators and insurers face over the potential expiration of the enhanced Affordable Care Act tax credits, and pledged to do whatever possible to ensure a smooth rate-setting process for plan year 2026 and future years.
Transition 2025
New FDA COO Has Background In ‘Transformational Change,’ Agency Reorganization
FDA has a new deputy commissioner for operations and chief operating officer, Barclay Butler, whose bio on the agency websites hints at more significant shifts for FDA, saying he “has significant experience leading organizations through significant transformational change in both the private and public sectors.”
DOJ Appeal To SCOTUS In Fed Firings Case Has Implications For HHS
Trump Gives OPM Authority To Fire HHS Workers As DOGE Firings Challenged In Court
Latest News
Sens. Mike Rounds (R-SD) and Martin Heinrich (D-NM), leaders on artificial intelligence policy issues in the Senate, have reintroduced a bill that would “create a program titled MedShield to leverage AI for national pandemic preparedness and response,” according to a March 25 announcement.
The newly formed Democratic Congressional Doctors Caucus hopes to work with the longstanding GOP Doctors Caucus to tackle Medicare Advantage (MA) overpayments, seeing this as a bipartisan opportunity as the Democratic doctors simultaneously blast Republicans for targeting Medicaid in their quest for $880 billion in health care savings in a quickly evolving GOP reconciliation bill that could include physician payment relief.
The Trump administration in its first legal filing on availability of the abortion drug mifepristone says FDA is entitled to the “utmost deference” on prescription drugs decisions -- an argument that could be used either to defend telehealth abortion under FDA’s current policies, or to argue for new restrictions if they’re put in place by new FDA leadership.